Literature DB >> 29552807

[Review for treatment effect and signaling pathway regulation of kidney-tonifying traditional Chinese medicine on osteoporosis].

Ya-Ping Xiao1,2,3, Jie Zeng1,2,3, Lin-Na Jiao1,2,3, Xiao-Yu Xu1,2,3.   

Abstract

The treatment effect and signaling pathway regulation effects of kidney-tonifying traditional Chinese medicine on osteoporosis have been widely studied, but there is no systematic summary currently. This review comprehensively collected and analyzed the traditional Chinese medicines on the treatment and signaling pathway regulation of osteoporosis in recent ten years, such as Epimedii Folium, Drynariae Rhizoma, Cnidii Fructus, Eucommiae Cortex, Psoraleae Fructus and Dipsaci Radix. Based on the existing findings, the following conclusions were obtained: ①kidney-tonifying traditional Chinese medicine treated osteoporosis mainly through BMP-Smads, Wnt/β-catenin, MAPK, PI3K/AKT signaling pathway to promote osteoblast bone formation and through OPG/RANKL/ RANK, estrogen, CTSK signaling pathway to inhibit osteoclasts of bone resorption. Epimedii Folium, Drynariae Rhizoma, Cnidii Fructus and Psoraleae Fructus up-regulated the expression of key proteins and genes of BMP-Smads and Wnt/β-catenin signaling pathways to promote bone formation. Epimedii Folium, Drynariae Rhizoma, Cnidii Fructus, Eucommiae Cortex, Psoraleae Fructus and Dipsaci Radix inhibited the bone resorption by mediating the OPG/RANKL/RANK signaling pathway. ②Kidney-tonifying traditional Chinese medicine prevented and treated osteoporosis through a variety of ways: icariin in Epimedii Folium, naringin in Drynariae Rhizoma, osthole in Cnidii Fructus and psoralen in Psoraleae Fructus can regulate BMP-Smads, Wnt/β-catenin signaling pathway to promote bone formation, but also activate OPG/RANKL/RANK, CTSK and other signaling pathways to inhibit bone resorption. ③The crosstalk of the signaling pathways and the animal experiments of the traditional Chinese medicine on the prevention and treatment of osteoporosis as well as their multi-target mechanism and comprehensive regulation need further clarification. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  bone metabolism ; kidney-tonifying traditional Chinese medicine ; osteoblast ; osteoclast ; osteoporosis ; signaling pathways

Mesh:

Substances:

Year:  2018        PMID: 29552807     DOI: 10.19540/j.cnki.cjcmm.20171106.002

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  6 in total

1.  Exploration of the Effect of Icariin on Nude Mice with Lung Cancer Bone Metastasis via the OPG/RANKL/RANK System.

Authors:  Zhao Ruilian; Gao Ying; Shen Hongmei; Guo Lihua
Journal:  Comput Math Methods Med       Date:  2022-05-28       Impact factor: 2.809

Review 2.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

3.  Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats.

Authors:  Lei Zhang; Zhirui Yang; Yidan Zhao; Xinyu Yang; Xintong Meng; Juan Liu; Yi Liu; Can Yan; Dan Yan
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

4.  In Silico Network Analysis of Ingredients of Cornus officinalis in Osteoporosis.

Authors:  Feiqi Huang; Huizhi Guo; Yuanbiao Wei; Xiao Zhao; Yangsheng Chen; Zhan Lin; Yanhui Zhou; Ping Sun
Journal:  Med Sci Monit       Date:  2021-04-02

5.  MicroRNA-197-3p Inhibits the Osteogenic Differentiation in Osteoporosis by Down-Regulating KLF 10.

Authors:  Murong You; Liang Zhang; Xiaoxiang Zhang; Yang Fu; Xieping Dong
Journal:  Clin Interv Aging       Date:  2021-01-11       Impact factor: 4.458

6.  Identified the Synergistic Mechanism of Drynariae Rhizoma for Treating Fracture Based on Network Pharmacology.

Authors:  Haixiong Lin; Xiaotong Wang; Ligang Wang; Hang Dong; Peizhen Huang; Qunbin Cai; Yingjie Mo; Feng Huang; Ziwei Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-20       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.